405 related articles for article (PubMed ID: 23859570)
1. SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.
Haerian BS; Baum L; Kwan P; Tan HJ; Raymond AA; Mohamed Z
Pharmacogenomics; 2013 Jul; 14(10):1153-66. PubMed ID: 23859570
[TBL] [Abstract][Full Text] [Related]
2. SCN1A and SCN2A polymorphisms are associated with response to valproic acid in Chinese epilepsy patients.
Shi L; Zhu M; Li H; Wen Z; Chen X; Luo J; Lin C; Zhang Z
Eur J Clin Pharmacol; 2019 May; 75(5):655-663. PubMed ID: 30693367
[TBL] [Abstract][Full Text] [Related]
3. Interstitial 2q24.3 deletion including SCN2A and SCN3A genes in a patient with autistic features, psychomotor delay, microcephaly and no history of seizures.
Celle ME; Cuoco C; Porta S; Gimelli G; Tassano E
Gene; 2013 Dec; 532(2):294-6. PubMed ID: 24080482
[TBL] [Abstract][Full Text] [Related]
4. Effect of SCN1Aand SCN2A gene polymorphisms on the efficacy of valproic acid treatment in Chinese children with epilepsy.
Bao Z; Li H; Hu J; Zhao R; Yan L; Zheng A
PLoS One; 2024; 19(6):e0304869. PubMed ID: 38837984
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression.
Kwan P; Poon WS; Ng HK; Kang DE; Wong V; Ng PW; Lui CH; Sin NC; Wong KS; Baum L
Pharmacogenet Genomics; 2008 Nov; 18(11):989-98. PubMed ID: 18784617
[TBL] [Abstract][Full Text] [Related]
6. Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy.
Baum L; Haerian BS; Ng HK; Wong VC; Ng PW; Lui CH; Sin NC; Zhang C; Tomlinson B; Wong GW; Tan HJ; Raymond AA; Mohamed Z; Kwan P
Hum Genet; 2014 May; 133(5):651-9. PubMed ID: 24337656
[TBL] [Abstract][Full Text] [Related]
7. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
[TBL] [Abstract][Full Text] [Related]
8. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
[TBL] [Abstract][Full Text] [Related]
9. Biological concepts in human sodium channel epilepsies and their relevance in clinical practice.
Brunklaus A; Du J; Steckler F; Ghanty II; Johannesen KM; Fenger CD; Schorge S; Baez-Nieto D; Wang HR; Allen A; Pan JQ; Lerche H; Heyne H; Symonds JD; Zuberi SM; Sanders S; Sheidley BR; Craiu D; Olson HE; Weckhuysen S; DeJonge P; Helbig I; Van Esch H; Busa T; Milh M; Isidor B; Depienne C; Poduri A; Campbell AJ; Dimidschstein J; Møller RS; Lal D
Epilepsia; 2020 Mar; 61(3):387-399. PubMed ID: 32090326
[TBL] [Abstract][Full Text] [Related]
10. Association of sodium voltage-gated channel genes polymorphisms with epilepsy risk and prognosis in the Saudi population.
Alghamdi MA; Al-Eitan LN; Asiri A; Rababa'h DM; Alqahtani SA; Aldarami MS; Alsaeedi MA; Almuidh RS; Alzahrani AA; Sakah AH; El Nashar EM; Otaif MY; Abdel Ghaffar NF
Ann Med; 2022 Dec; 54(1):1938-1951. PubMed ID: 35801810
[TBL] [Abstract][Full Text] [Related]
11. Association between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysis.
Bao Y; Liu X; Xiao Z
Neurol Sci; 2018 Jun; 39(6):1065-1072. PubMed ID: 29582177
[TBL] [Abstract][Full Text] [Related]
12. Association Between
Li M; Zhong R; Lu Y; Zhao Q; Li G; Lin W
Front Neurol; 2020; 11():591828. PubMed ID: 33519675
[No Abstract] [Full Text] [Related]
13. Genetic polymorphisms in SCN2A are not associated with epilepsy risk and AEDs response: evidence from a meta-analysis.
Yang R; Qian R; Chen K; Yi W; Sima X
Neurol Sci; 2021 Jul; 42(7):2705-2711. PubMed ID: 33914194
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous deletion of SCN2A and SCN3A in a patient with autism spectrum disorder and Tourette syndrome: a case report.
Nickel K; Tebartz van Elst L; Domschke K; Gläser B; Stock F; Endres D; Maier S; Riedel A
BMC Psychiatry; 2018 Aug; 18(1):248. PubMed ID: 30071822
[TBL] [Abstract][Full Text] [Related]
15. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children.
Liu M; Mao J; Xu H; Wang J; Zhao P; Xu Q; Du Z
Epilepsy Res; 2020 Dec; 168():106485. PubMed ID: 33096315
[TBL] [Abstract][Full Text] [Related]
16. Association between SCN1A polymorphism and carbamazepine responsiveness in epilepsy: A meta-analysis.
Zhang X; Liu J; Ye J
Epilepsy Res; 2021 Oct; 176():106627. PubMed ID: 34218210
[TBL] [Abstract][Full Text] [Related]
17. Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children: A protocol for systematic review and meta-analysis.
Wen Z; Chen J; Zhu B; Lu Y; Chen L
Medicine (Baltimore); 2021 May; 100(20):e25831. PubMed ID: 34011048
[TBL] [Abstract][Full Text] [Related]
18. Missense mutations in sodium channel SCN1A and SCN2A predispose children to encephalopathy with severe febrile seizures.
Saitoh M; Ishii A; Ihara Y; Hoshino A; Terashima H; Kubota M; Kikuchi K; Yamanaka G; Amemiya K; Hirose S; Mizuguchi M
Epilepsy Res; 2015 Nov; 117():1-6. PubMed ID: 26311622
[TBL] [Abstract][Full Text] [Related]
19. SCN1A IVS5N+5 polymorphism and response to sodium valproate: a multicenter study.
Haerian BS; Baum L; Tan HJ; Kwan P; Raymond AA; Saruwatari J; Nakagawa K; Mohamed Z
Pharmacogenomics; 2012 Oct; 13(13):1477-85. PubMed ID: 23057548
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiological Differences between the Same Pore Region Mutation in SCN1A and SCN3A.
Chen YJ; Shi YW; Xu HQ; Chen ML; Gao MM; Sun WW; Tang B; Zeng Y; Liao WP
Mol Neurobiol; 2015; 51(3):1263-70. PubMed ID: 24990319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
